Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme

2013 ◽  
Vol 37 (4) ◽  
pp. 469-473
Author(s):  
Priscilla Sassoli de Bianchi ◽  
Cinzia Campari ◽  
Silvia Mancini ◽  
Orietta Giuliani ◽  
Patrizia Landi ◽  
...  
1986 ◽  
Vol 1 (4) ◽  
pp. 248-250 ◽  
Author(s):  
N. C. Armitage ◽  
P. A. Farrands ◽  
C. M. Mangham ◽  
J. D. Hardcastle

1997 ◽  
Vol 4 (3) ◽  
pp. 142-146 ◽  
Author(s):  
G Castiglione ◽  
M Zappa ◽  
G Grazzini ◽  
C Sani ◽  
A Mazzotta ◽  
...  

Objective— To compare the costs of colorectal cancer (CRC) screening by two faecal occult blood tests (FOBT)—namely, Hemoccult (guaiac based) and reversed passive haemagglutination (RPHA) tests. RPHA was interpreted according to two positivity thresholds (+ or +/-). Methods— Attenders performed both tests. Subjects with a positive FOBT test were invited to have a complete exploration of the colon. The total costs for every 10 000 screened subjects and costs for each unit of result (screened subject, or patient with adenoma/s or cancer detected) were calculated for both tests. Results— 8353 subjects were enrolled. A total of 2109 repeated screening after two years. RPHA(+ and +/-) showed the highest and RPHA(+) the lowest positivity rate at first screening. The Hemoccult positivity rate was highest at repeat screening. Total costs of screening by RPHA(+ and +/-) were highest as this method had the highest recall rate. Screening by RPHA(+) was the least costly. Costs for each screened subject were highest for RPHA(+ and +/-) and lowest for RPHA(+). Costs for each cancer detected were lowest for RPHA(+) and highest for Hemoccult or RPHA(+ and +/-) in subjects aged > 49 or < 50, respectively. Costs for subjects with detected adenoma/s of > 9 mm were lowest for RPHA(+ and +/-) and highest for Hemoccult. At repeat screening total costs of RPHA(+ and +/-) were lower than at first screening, whereas for each subject with cancer or adenoma/s costs were increased. Conclusions— Our data confirm that screening by RPHA is more cost effective than by Hemoccult.


2019 ◽  
Vol 26 (4) ◽  
pp. 191-196 ◽  
Author(s):  
Anna Goulding ◽  
Gavin RC Clark ◽  
Annie S Anderson ◽  
Judith A Strachan ◽  
Callum G Fraser ◽  
...  

Objectives Changes in the prevalence of faecal occult blood test positivity over time have not been previously reported, but could have important implications. This study examined the positivity of the initial guaiac faecal occult blood test, a surrogate marker for colorectal bleeding, in participants aged 50 in a national bowel screening programme. Methods Data from the Scottish Bowel Screening Programme were used to study the initial positivity of the guaiac faecal occult blood test between 2007 and 2017. Positive predictive values of the testing process for colorectal cancer and adenoma were assessed over the same time period. Results Across Scotland, the initial guaiac faecal occult blood test positivity increased from 4.1 to 10.8%. In NHS Grampian and NHS Fife, two of the three NHS Boards which began roll-out of screening in 2007, it increased from 4.0 to 10.9%. In the Scottish Bowel Screening Programme, the positive predictive value declined from 11.0 to 6.6% for colorectal cancer and increased from 31.6 to 39.8% for adenoma. Conclusions In the Scottish programme over a decade, initial guaiac faecal occult blood test positivity increased in participants aged 50. This may be associated with changes in lifestyle and might have implications for screening clinical outcomes, including positive predictive value.


The Lancet ◽  
1996 ◽  
Vol 348 (9040) ◽  
pp. 1472-1477 ◽  
Author(s):  
Jack D Hardcastle ◽  
Jocelyn O Chamberlain ◽  
Michael HE Robinson ◽  
Susan M Moss ◽  
Satya S Amar ◽  
...  

2014 ◽  
Vol 27 (Suppl 2) ◽  
pp. 2S87-2S97
Author(s):  
Bohumil Seifert ◽  
Ondřej Májek ◽  
Miroslav Zavoral ◽  
Norbert Král ◽  
Štěpán Suchánek ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document